Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Department of Error] Department of Error

Oosthuizen JC, Doody J. De-intensified treatment in human papillomavirus-positive oropharyngeal cancer. Lancet 2019; 393: 5–7—In the fifth paragraph of this Comment (published Online First on Nov 15, 2018), the study by Maura Gillison and colleagues was incorrectly referred to as a phase 2 study, rather than a non-inferiority study. The fourth sentence of this paragraph should read “This difference between the two study designs might reflect regional practice patterns, with cisplatin commonly substituted with cetuximab in older patients…”.